 |
9 Diseases |  |
32 Trials |
|
32 Trials |  |
764 News |  |
| «12345678910 |
- Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
New P1 trial: Trial of Linaclotide to Demonstrate Colorectal Bioactivity in Health Volunteers (clinicaltrials.gov) - Jul 28, 2013
P1, N=18, Not yet recruiting, Sponsor: Fox Chase Cancer Center
- |||||||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
New P3 trial: A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (clinicaltrials.gov) - Jun 17, 2013
P3, N=800, Recruiting, Sponsor: AstraZeneca
- ||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
New P2 trial: A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome (clinicaltrials.gov) - Oct 24, 2012
P2, N=559, Completed, Sponsor: Astellas Pharma Inc
- |||||||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
New P3 trial: Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating (clinicaltrials.gov) - Jul 15, 2012
P3, N=487, Completed, Sponsor: Forest Laboratories
- ||||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion: An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation (clinicaltrials.gov) - Mar 15, 2012
P3, N=1743, Completed, Sponsor: Ironwood Pharmaceuticals, Inc.
Active, not recruiting --> Completed
- | Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion: Efficacy of System Constellations in a General Population (clinicaltrials.gov) - Feb 7, 2012
P2/3, N=216, Completed, Sponsor: University of Heidelberg
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion: An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation (clinicaltrials.gov) - Jan 26, 2012
P3, N=1557, Completed, Sponsor: Forest Laboratories
Recruiting --> Completed Active, not recruiting --> Completed
- | Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Trial completion: A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects (clinicaltrials.gov) - Sep 21, 2011
P1, N=44, Completed, Sponsor: Astellas Pharma Inc
Active, not recruiting --> Completed Recruiting --> Completed
- | Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
New P1 trial: A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects (clinicaltrials.gov) - Aug 30, 2011
P1, N=44, Completed, Sponsor: Astellas Pharma Inc